Ping Lung Chan

Dr. Ping Lung Chan


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2009 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
GQGang Qin
Gang Qin
HMHuawei Mao
Huawei Mao
JZJian Zheng
Jian Zheng
SSSin Fun Sia
Sin Fun Sia
YLYinping Liu
Yinping Liu
Wenwei TuWenwei Tu
Wenwei Tu
BackgroundInfluenza virus is a cause of substantial annual morbidity and mortality worldwide. The potential emergence of a new pandemic strain (eg, a

1 July 2010 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
Wenwei TuWenwei Tu
Wenwei Tu
HMHuawei Mao
Huawei Mao
JZJian Zheng
Jian Zheng
YLYinping Liu
Yinping Liu
SCSusan S. Chiu
Susan S. Chiu
YLYu-Lung Lau
Yu-Lung Lau
While few children and young adults have cross-protective antibodies to the pandemic H1N1 2009 (pdmH1N1) virus, the illness remains mild. The biological reasons for these epidemiological observations are unclear. In this study, we demonstrate that the bulk memory cytotoxic T lymphocytes (CTLs) established by seasonal influenza viruses from healthy individuals who have not been exposed to pdmH1N1 can directly lyse pdmH1N1-infected target cells and produce gamma interferon (IFN-γ) and tumor necrosis factor alpha (TNF-α). Using influenza A virus matrix protein 1 (M158-66) epitope-specific CTLs isolated from healthy HLA-A2+individuals, we further found that M158-66epitope-specific CTLs efficiently killed both M158-66peptide-pulsed and pdmH1N1-infected target cells ex vivo. These M158-66-specific CTLs showed an effector memory phenotype and expressed CXCR3 and CCR5 chemokine receptors. Of 94 influenza A virus CD8 T-cell epitopes obtained from the Immune Epitope Database (IEDB), 17 epitopes are conserved in pdmH1N1, and more than half of these conserved epitopes are derived from M1 protein. In addition, 65% (11/17) of these epitopes were 100% conserved in seasonal influenza vaccine H1N1 strains during the last 20 years. Importantly, seasonal influenza vaccination could expand the functional M158-66epitope-specific CTLs in 20% (4/20) of HLA-A2+individuals. Our results indicated that memory CTLs established by seasonal influenza A viruses or vaccines had cross-reactivity against pdmH1N1. These might explain, at least in part, the unexpected mild pdmH1N1 illness in the community and also might provide some valuable insights for the future design of broadly protective vaccines to prevent influenza, especially pandemic influenza.

15 September 2008 in Blood
Verified
Journal Article
Open access
PDF file
Wenwei TuWenwei Tu
Wenwei Tu
YLYu-Lung Lau
Yu-Lung Lau
JZJian Zheng
Jian Zheng
YLYinping Liu
Yinping Liu
PCPing Lung Chan
Ping Lung Chan
DLDavid B. Lewis
David B. Lewis
CD4+CD25+Foxp3+ regulatory T cells (Treg) play an important role in the induction and maintenance of immune tolerance. Although adoptive transfer of bulk populations of Treg can prevent or treat T cell–mediated inflammatory diseases and transplant allograft rejection in animal models, optimal Treg immunotherapy in humans would ideally use antigen-specific rather than polyclonal Treg for greater specificity of regulation and avoidance of general suppression. However, no robust approaches have been reported for the generation of human antigen-specific Treg at a practical scale for clinical use. Here, we report a simple and cost-effective novel method to rapidly induce and expand large numbers of functional human alloantigen-specific Treg from antigenically naive precursors in vitro using allogeneic nontransformed B cells as stimulators. By this approach naive CD4+CD25− T cells could be expanded 8-fold into alloantigen-specific Treg after 3 weeks of culture without any exogenous cytokines. The induced alloantigen-specific Treg were CD45RO+CCR7− memory cells, and had a CD4high, CD25+, Foxp3+, and CD62L (L-selectin)+ phenotype. Although these CD4highCD25+Foxp3+ alloantigen-specific Treg had no cytotoxic capacity, their suppressive function was cell-cell contact dependent and partially relied on cytotoxic T lymphocyte antigen-4 expression. This approach may accelerate the clinical application of Treg-based immunotherapy in transplantation and autoimmune diseases.

1 May 2010 in Journal of Virology
Verified
Journal Article
Open access
PDF file
HMHuawei Mao
Huawei Mao
Wenwei TuWenwei Tu
Wenwei Tu
YLYinping Liu
Yinping Liu
GQGang Qin
Gang Qin
JZJian Zheng
Jian Zheng
YLYu-Lung Lau
Yu-Lung Lau
Natural killer (NK) cells keep viral infections under control at the early phase by directly killing infected cells. Influenza is an acute contagious respiratory viral disease transmitted from host-to-host in the first few days of infection. The evasion of host innate immune defenses including NK cells is important for its success as a viral pathogen of humans and animals. NK cells encounter influenza virus within the microenvironment of infected cells. It therefore is important to investigate the direct effects of influenza virus on NK cell activity. Recently we demonstrated that influenza virus directly infects human NK cells and induces cell apoptosis to counter their function (H. Mao, W. Tu, G. Qin, H. K. W. Law, S. F. Sia, P.-L. Chan, Y. Liu, K.-T. Lam, J. Zheng, M. Peiris, and Y.-L. Lau, J. Virol. 83:9215-9222, 2009). Here, we further demonstrated that both the intact influenza virion and free hemagglutinin protein inhibited the cytotoxicity of fresh and interleukin-2 (IL-2)-activated primary human NK cells. Hemagglutinin bound and internalized into NK cells via the sialic acids. This interaction did not decrease NKp46 expression but caused the downregulation of the ζ chain through the lysosomal pathway, which caused the decrease of NK cell cytotoxicity mediated by NKp46 and NKp30. The underlying dysregulation of the signaling pathway involved ζ chain downregulation, leading to decreased Syk and ERK activation and granule exocytosis upon target cell stimulation, finally causing reduced cytotoxicity. These findings suggest that influenza virus developed a novel strategy to evade NK cell innate immune defense that is likely to facilitate viral transmission and also contribute to virus pathogenesis.

15 September 2009 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JZJian Zheng
Jian Zheng
YLYinping Liu
Yinping Liu
GQGang Qin
Gang Qin
PCPing Lung Chan
Ping Lung Chan
HMHuawei Mao
Huawei Mao
WTWenwei Tu
Wenwei Tu
Although recent studies have focused on CD4+ regulatory T cells (Treg), CD8+ Treg have also been reported to play important roles in the induction and maintenance of immune tolerance. Adoptive transfer of CD8+ Treg in rodents or induction of CD8+ Treg in humans can prevent or treat allograft rejection and autoimmune diseases. However, no approaches have been reported for the generation of human Ag-specific CD8+ Treg at a practical scale for clinical use. Here, we found that two novel CD8+ T cell subsets with different levels of CD8 surface expression, CD8high and CD8low, could be induced from naive CD8+ precursors in vitro by allogeneic CD40-activated B cells, whereas only CD8high T cells were alloantigen-specific Treg with relatively poor alloantigen-specific cytotoxicity. Importantly, alloantigen-specific CD8high Treg could be induced and expanded from naive CD8+CD25− T cells at a large scale after 3 wk of culture without exogenous cytokines. These induced alloantigen-specific Treg were CD45RO+ and CCR7− memory cells, and they expressed Foxp3, CD25, CD27, CD28, and CD62L. The induction and expansion of CD8high Treg by CD40-activated B cells were dependent on endogenously expressed IFN-γ, IL-2, IL-4, and CTLA-4. This approach may facilitate the clinical application of CD8+ Treg-based immunotherapy in transplantation and autoimmune diseases.

2 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JZJian Zheng
Jian Zheng
PCPing Lung Chan
Ping Lung Chan
YLYinping Liu
Yinping Liu
GQGang Qin
Gang Qin
ZXZheng Xiang
Zheng Xiang
Wenwei TuWenwei Tu
Wenwei Tu
Inducible co-stimulator (ICOS) is a member of CD28/Cytotoxic T-lymphocyte Antigen-4 (CTLA-4) family and broadly expressed in activated CD4+ T cells and induced regulatory CD4+ T cells (CD4+ iTreg). ICOS-related signal pathway could be activated by the interaction between ICOS and its ligand (ICOSL). In our previous work, we established a cost-effective system to generate a novel human allo-antigen specific CD4hi Treg by co-culturing their naïve precursors with allogeneic CD40-activated B cells in vitro. Here we investigate the role of ICOS in the generation and function of CD4hi Treg by interrupting ICOS-ICOSL interaction with ICOS-Ig. It is found that blockade of ICOS-ICOSL interaction impairs the induction and expansion of CD4hi Treg induced by allogeneic CD40-activated B cells. More importantly, CD4hi Treg induced with the addition of ICOS-Ig exhibits decreased suppressive capacity on alloantigen-specific responses. Dysfunction of CD4hi Treg induced with ICOS-Ig is accompanied with its decreased exocytosis and surface CTLA-4 expression. Through inhibiting endocytosis with E64 and pepstatin A, surface CTLA-4 expression and suppressive functions of induced CD4hi Treg could be partly reversed. Conclusively, our results demonstrate the beneficial role of ICOS-ICOSL signal pathway in the generation and function of CD4hi Treg and uncover a novel relationship between ICOS and CTLA-4.